Latest Posts

Genome Canada launched the Genomics in Society Interdisciplinary Research Teams Program. The program aims to support and enhance GE3LS research that addresses important and overarching challenges that affect the adoption and uptake of the outcomes from genomics research and/or accelerate the synthesis and dissemination of research pertinent to users. Génome Quebec wishes good luck to all…

On January 28, 2019, Génome Québec took part in pre-budget consultations led by the ministère des Finances du Québec.  A submission was tabled. Developed with a focus on wealth creation and economic development, the document aligns with our 2018-2023 strategic plan. It features five recommendations:   Support the creation and launch of a genomic data…

Congratulations to McGill-led EpiShare project, now part of the Global Alliance for Genomics and Health (GA4GH) Driver Project. To learn more about Pr. Guillaume Bourque EpiShare project and its role in the GA4GH, click here.

Montréal, Monday, January, 21, 2019 – It was with profound sadness that Génome Québec learned of the passing of eminent researcher and physician, Dr. Fernand Labrie.  Throughout his career, Dr. Labrie built a solid reputation among leading medical research scientists. He was behind many discoveries in endocrinology in areas including prostate cancer and hormone therapy…

Génome Québec is pleased to highlight the unprecedented advances of Prof. Jacques Simard’s work, co-author of two important studies on the risk of developing breast cancer.   Thanks to this work, a simple saliva test could help to gauge, with unprecedented accuracy, a woman’s risk of developing breast cancer during her lifetime, according to an international…

Daniel Coderre, President and CEO of Génome Québec, is pleased to announce the appointment of Serge Marchand as Vice President of Scientific Affairs – a decision unanimously endorsed by the Board of Directors. He will be taking up his duties on January 28, 2019. Mr. Marchand has over 30 years of experience in the Québec…

The team of Dr. Claude Perreault at the Institute for Research in Immunology and Cancer (IRIC) at Université de Montréal has successfully shown how a vaccine could work to fight several types of cancers. The team’s work was published yesterday in Science Translational Medicine and  represents a major breakthrough. The team at IRIC looked for a solution in an unusual…

Génome Québec is pleased to be one of the partners of EFFERVESCENCE, a major event in the life science and health technologies sector. EFFERVESCENCE is a group of fifteen partners that came together to organize this opportunity for researchers, companies and stakeholders to hold meetings, build relationships, participate in inspiring conferences and discover new developments in…

During the 31st edition of the Entretiens Jacques Cartier (EJC) being held in France, Génome Québec is pleased to announce that an international tripartite partnership agreement has been signed with the Université Jean Monnet de Saint-Étienne – Université de Lyon and the Cancéropôle Lyon Auvergne-Rhône-Alpes (CLARA).  According to Daniel Coderre, “by transferring know-how and expertise and by…

The Québec City Healthcare Industry Forum (FISQ) will take place December 5 and 6, at the Manège militaire Voltigeurs in Québec. Organized by Québec International, in collaboration with BIOQuébec, Génome Québec, Innovative medicines Canada and Norton Rose Fulbright. The goal of the 12th Québec City Healthcare Industry Forum is to realize the input from big data and explore the potential…